Coronavirus vaccines were just rolling out in December when more than 1,000 staffers at Cedars-Sinai Medical Center in Los Angeles volunteered for a sweeping study. The goal: pinpoint how immune reactions to the jab might vary.
By last month, a clear pattern in the data "popped out at us,” said research leader Susan Cheng. Those who had recovered from COVID-19 responded to their first shot so robustly that the results rivaled never-infected colleagues who had received both shots. The implication was clear. If you’ve had COVID-19, you may only need one of the two doses recommended by Pfizer and Moderna.
"We did not expect that this was going to jump out like a smoking gun,” said Cheng, who co-authored the Nature Medicine write-up. In fact, if you already had the virus, your immune response after one vaccine is likely to be even better than a never-infected person’s after two, according to Italian research just out in the New England Journal of Medicine.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.